GLP-1 Receptor Agonists (GLP-1 RAs)

Treatments and therapies Medicines

Last Updated: September 16, 2024

Medically reviewed by NKF Patient Education Team

GLP-1 RAs help slow CKD and lower heart disease risk for people with type 2 diabetes and/or obesity, but it’s important to weigh risks and benefits.

Table of Contents

About GLP-1 Receptor Agonists (GLP-1 RAs)

GLP-1 receptor agonists (GLP-1 RAs) are a type of prescription medicine commonly recommended for people with type 2 diabetes and/or obesity. Combined with healthy eating habits and physical activity, GLP-1 RAs can help you keep your blood sugar levels in the goal range and lose weight (if needed). For people living with chronic kidney disease (CKD) or at risk for CKD, this means GLP-1 RAs can help slow down the CKD disease process by addressing these two risk factors. New research suggests GLP-1 RAs may also have a direct effect on helping the kidneys stay healthy.

People living with CKD are at an increased risk of heart attack or stroke, also known as cardiovascular disease (CVD). Most GLP-1 RAs have been shown in clinical trials to help lower the risk of CVD, offering another benefit for people living with CKD.

Uses

GLP-1 RAs are approved by the United States Food and Drug Administration (FDA) to treat adults with type 2 diabetes. A few GLP-1 RAs have also been approved to treat adults with obesity. Some GLP-1RAs are also approved for use in children as young as 12 years of age who are living with type 2 diabetes and/or obesity.

Current guidelines recommend a long-acting GLP-1 RA for adults living with type 2 diabetes and CKD who have not yet reached their diabetes goals with metformin and an SGLT2 inhibitor.

How They Work

GLP-1 stands for “glucagon-like peptide-1”. GLP-1 is a hormone (a natural chemical messenger or signal) that your small intestine naturally makes in response to meals. Hormones are a part of your body’s messenger service, sending messages to and from different parts of your body to keep things running smoothly. 

The four main messages that GLP-1 sends to other parts of your body include:

  • Telling your pancreas to release insulin to help digest meals
  • Telling your liver to slow the release of stored sugars (to keep blood sugar from going too high)
  • Slowing down how quickly food leaves your stomach to increase digestion
  • Increasing the signals to your brain that let you know when you are full (also known as satiety)

The GLP-1 RAs are medicines designed to work like the GLP-1 hormone your body naturally makes and help to amplify (increase) its effects. 

The direct effects of GLP-1 RAs on improving kidney health are not fully known. Leading research suggests they may also help with lowering inflammation in the kidney and/or removing extra sodium from the body, but more research is needed to know for sure. Studies have also shown that GLP-1 RAs help decrease urine albumin-creatinine ratio (uACR) levels for people with albuminuria, though not as much as SGLT2 inhibitors, ACE inhibitors/ARBs, or nsMRAs.

Types

There are many types of GLP-1 RAs available today, with more undergoing clinical trials. The main differences between them include how you take them (by injection or by mouth), how often you take them, and in which disease state(s) they were directly studied (type 2 diabetes or obesity). 

Short-acting GLP-1 RAs that are taken every day include:

  • Exenatide (Byetta): twice-daily injection 
  • Liraglutide 
    • Victoza (for type 2 diabetes): once-daily injection 
    • Saxenda (higher doses for obesity): once-daily injection
  • Semaglutide (Rybelsus): once-daily tablet (taken by mouth) 

Long-acting GLP-1 RAs that are taken once weekly include:

  • Dulaglutide (Trulicity)
  • Exenatide extended-release (Bydureon) 
  • Semaglutide 
    • Ozempic (for type 2 diabetes)
    • Wegovy (higher doses for obesity)
  • Tirzepatide* 
    • Mounjaro (for type 2 diabetes)
    • Zepbound (higher doses for obesity)

*In addition to increasing GLP-1 activity, tirzepatide also increases GIP, another hormone that is very similar. While technically considered a “dual GIP/GLP-1 RA”, it has many of the same effects as the other GLP-1 RAs.

 

Effectiveness

GLP-1 RAs offer many health benefits including improved blood glucose (sugar) and A1C levels and weight loss. Some GLP-1 RAs have also been shown in clinical trials to lower the risk of heart attack or stroke. 

A major clinical trial studying the effects of once weekly semaglutide on kidney health for people living with type 2 diabetes found once weekly semaglutide helped slow the CKD disease process and lowered the risk of developing kidney failure. People taking semaglutide group also had a lower risk of dying from kidney disease or cardiovascular disease. This is the first major study looking directly at the effect of GLP-1 RAs on CKD. Similar trials with other GLP-1 RAs are ongoing, including in people with CKD and obesity without type 2 diabetes.

Side Effects

Nausea and/or vomiting

These side effects are mostly related to the GLP-1 RA slowing down how quickly food leaves your stomach. Filling your stomach up too fast and/or with too much food increases this risk. Pay special attention to how quickly you eat your meals, especially when you first start this medicine. Eating smaller meals, eating slowly, and stopping just before you are full can help decrease these side effects. 

 

To lower your chances of nausea and vomiting, your healthcare professional will start you on a low dose and increase your dose slowly. If you are having these side effects after a dose increase, you may need to go back down on your dose for a bit and try again to increase it later.

 

Talk with your healthcare professional right away if you have completely lost your desire to eat. This may be a sign that your dose is too high or that you may not be a good candidate for a GLP-1 RA.

Constipation and/or diarrhea

These side effects are also related to the effects of GLP-1 RA on your body’s digestion process. Some people may experience constipation while others experience diarrhea. It is not known why people respond so differently. These side effects usually get better or go away entirely over time. If that is not your experience, talk with your healthcare professional to see what might be going on. You may need to lower your dose or switch to a different GLP-1 RA to see if your body can tolerate that better.

Low blood sugar (hypoglycemia)

Based on how they work in the body, GLP-1 RAs should not cause low blood sugar. However, the risk is increased when used together with insulin and/or other medicines that increase insulin levels. These include glipizide, glimepiride, and glyburide. If you are on one of these other medicines, your healthcare professional may ask you to lower the dose or stop it when starting a GLP-1 RA. You may also be asked to follow your blood sugar levels more closely during this change process to see if further dose changes are needed.

Injection site reactions

This is not very common but always possible whenever you give a medicine by injection. Symptoms may include redness, swelling, and/or pain where you gave your injection. Cleaning your injection site with rubbing alcohol before each dose and giving each dose at a different injection site can help prevent these reactions. For example, if your last dose was on the left side of your abdomen (belly area), give your next dose on the right side.

Be sure to tell your healthcare professional about any side effects you might be having and work together to find a solution. Do not adjust your dose without talking to your healthcare professional first. 

Additional considerations

Pregnancy

GLP-1 RAs are not recommended during pregnancy. Animal studies have shown risks of harm to the baby, and there are limited data in pregnant women. If it is possible for you to become pregnant, plan to use an effective and reliable form of birth control while taking a GLP-1 RA. 

Talk to your healthcare professional as soon as possible if you are pregnant or planning to become pregnant. This is especially true for the long-acting (once weekly) GLP-1 RAs as they can take several weeks to be fully removed from your body.

Questions for your healthcare team

  • Should I be considering a GLP-1 RA for my CKD and other health conditions?
  • Is there one GLP-1 RA that might be a better fit for me than the others based on my preferences and other medical conditions?
  • Am I at a higher risk for any of the side effects caused by GLP-1 RAs?
  • [If you are having side effects:] What can I do to help these side effects go away?
  • How will I know if this GLP-1 RA is working for me?

How helpful was this content?

This content is provided for informational use only and is not intended as medical advice or as a substitute for the medical advice of a healthcare professional.
© 2024 National Kidney Foundation, Inc.